|
|
Build Your Online Product Catalogs?
| Product Name: |
Dapoxetine
|
| Supply Ability: |
|
| Related proudcts |
dapoxetine, butoconazole nitrate, d-xylose, |
| Specifications |
Enterprise standard |
| Price Term: |
CNF, CIF |
| Port of loading: |
|
| Minimum Order |
|
| Unit Price: |
|
|
Dapoxetine was created by Eli Lilly and Co***ny and is credited to biochemist David T. Wong. Originally known as LY 210448, it was being developed by Lilly as an antidepressant. Eli Lilly sold the patent to Johnson & Johnson for $65 million and future royalties in December 2003. In 2004, dapoxetine was submitted to the FDA in the form of dapoxetine hydrochloride by the ALZA Corporation and its parent co***ny, Johnson & Johnson, for the treatment of premature ejaculation with a New Drug Application (NDA). However, the FDA issued a "not approvable" letter for dapoxetine, requiring additional clinical study.[8] Two further clinical trials were completed in 2006, and approval is under review by the FDA.
Dapoxetine has been submitted for approval in the European Union and is being reviewed. In 2009, dapoxetine received approval in Sweden, Finland, ***in, Portugal, Germany, Austria, Italy, and New Zealand. Approvals for dapoxetine are also anticipated in other European countries as well. In addition, filings for approval have been submitted in Canada, Australia, Mexico, Turkey, and six other countries.[5]
|
| Company: |
Ningbo Highmomedical Technology Co.,Ltd
|
| Contact: |
Mr. Chen Haitao |
| Address: |
No.19 TianRong Street, Daxing Bio-medicine Industry Park, Zhongguancun Science Park , Beijing ,China |
| Postcode: |
315000 |
| Tel: |
86-15867886276 |
| Fax: |
86-574-87297028 |
| E-mail: |
|
|
|
|
Home
